{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:04:53Z","timestamp":1780031093997,"version":"3.53.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      There is limited data on how veterinarians implement multimodal therapies for managing canine osteoarthritis (OA). The primary aim of this study was to describe how OA is managed by veterinarians with diverse backgrounds. The secondary aim was to report perceived side effects associated with bedinvetmab (Librela\n                      <jats:sup>TM<\/jats:sup>\n                      ) and grapiprant. The authors hypothesized that variation exists in management patterns among veterinarians with different training backgrounds and experience levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional, observational, voluntary response survey was distributed to veterinarians assessing respondent demographics, diagnostic approaches, the frequency of treatment use for canine OA, and perceived adverse events associated with grapiprant and bedinvetmab.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      373 responses were analyzed. Non-steroidal anti-inflammatory drugs (NSAIDs) were the most prescribed drug class, and gabapentin, bedinvetmab, and polysulfated glycosaminoglycan (Adequan\n                      <jats:sup>\u00ae<\/jats:sup>\n                      ) were the most prescribed non-NSAID medications. The most used nutraceutical and non-pharmacologic treatments were omega-3 fatty acids and weight management. Fifty-three percent of respondents used imaging whenever possible to confirm OA. Those with higher levels of training (specialty training, rehabilitation certificates) and more years of experience used imaging more often. American College of Veterinary Surgery (ACVS) diplomates were less likely to use bedinvetmab and cannabainoids (CBD). American College of Veterinary Sports Medicine and Rehabilitation (ACVSMR) diplomates and rehabilitation-certified veterinarians were less likely to use glucosamine\/chondroitin and bedinvetmab and more likely to use ketamine, amantadine, polysulfated glycosaminoglycan, green-lipped mussel, CBD, undenatured type II collagen, eggshell membrane, curcumin, and Boswellia serrata. Diplomates, rehabilitation-certified veterinarians, and more experienced veterinarians used non-pharmacological treatments, including intra-articular injections more often. The most reported perceived side effects of bedinvetmab were paresis\/ataxia\/proprioceptive deficits (31%) and polyuria\/polydipsia (25%). Diarrhea (33%), and vomiting (31%) were the most reported perceived side effects of grapiprant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There is variation in multimodal approaches to canine OA management influenced by both training and years of clinical experience. While NSAIDs, omega-3 fatty acids, and weight management remain foundational, this study demonstrates a spectrum of utilized adjunctive strategies. The differences highlight opportunities for further research into the safety and efficacy of commonly used therapies. Reported perceived adverse events associated with bedinvetmab and grapiprant underscore the need for pharmacovigilance and further research investigating safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fvets.2026.1814641","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:46:49Z","timestamp":1780030009000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Variations in the management of canine osteoarthritis: a cross-sectional survey of veterinary practices"],"prefix":"10.3389","volume":"13","author":[{"given":"Elyza","family":"Bird","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, University of Florida","place":["Gainesville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Miscioscia","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, University of Florida","place":["Gainesville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Montalbano","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, University of Florida","place":["Gainesville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Colee","sequence":"additional","affiliation":[{"name":"Institute of Food and Agricultural Sciences Statistical Consulting Unit, University of Florida","place":["Gainesville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Repac","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, University of Florida","place":["Gainesville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1201\/9781315368443","author":"Fox","year":"2016","journal-title":"Multimodal Management of Canine Osteoarthritis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/s0195-5616(97)50076-3","article-title":"Osteoarthritis. Joint anatomy, physiology, and pathobiology","volume":"27","author":"Johnston","year":"1997","journal-title":"Vet Clin North Am Small Anim Pract."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1038\/s41598-018-23940-z","article-title":"Prevalence, duration and risk factors for appendicular osteoarthritis in a UK dog population under primary veterinary care","volume":"8","author":"Anderson","year":"2018","journal-title":"Sci Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/jsap.13500","article-title":"Identification of canine osteoarthritis using an owner-reported questionnaire and treatment monitoring using functional mobility tests","volume":"63","author":"Wright","year":"2022","journal-title":"J Small Anim Pract."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.21203\/rs.3.rs-3580885\/v1","article-title":"Prevalence of radiographic appendicular osteoarthritis and associated clinical signs in young dogs","volume":"14","author":"Enomoto","year":"2024","journal-title":"Sci Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.tvjl.2022.105868","article-title":"Relationships among owner consideration of euthanasia, caregiver burden, and treatment satisfaction in canine osteoarthritis","volume":"286","author":"Spitznagel","year":"2022","journal-title":"Vet J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fvets.2025.1565922","article-title":"A proposed framework for practical multimodal management of osteoarthritis in growing dogs","volume":"27","author":"Marcellin-Little","year":"2025","journal-title":"Vet Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1137888","DOI":"10.3389\/fvets.2023.1137888","article-title":"COAST Development Group's international consensus guidelines for the treatment of canine osteoarthritis","volume":"10","author":"Cachon","year":"2024","journal-title":"Front Vet Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1053\/j.tcam.2009.10.005","article-title":"Diagnosis and treatment of osteoarthritis","volume":"25","author":"Rychel","year":"2010","journal-title":"Top Companion Anim Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"105379","DOI":"10.1016\/j.tvjl.2019.105379","article-title":"Placebo-controlled pilot study of the effects of an eggshell membrane-based supplement on mobility and serum biomarkers in dogs with osteoarthritis","volume":"253","author":"Muller","year":"2019","journal-title":"Vet J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0252279","DOI":"10.1371\/journal.pone.0252279","article-title":"Clinical efficacy of Curcuvet and Boswellic acid combined with conventional nutraceutical product: an aid to canine osteoarthritis","volume":"16","author":"Caterino","year":"2021","journal-title":"PLoS ONE"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/vetsci10010002","article-title":"physiotherapeutic strategies and their current evidence for canine osteoarthritis","volume":"10","author":"Mille","year":"2022","journal-title":"Vet Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s12917-025-05036-9","article-title":"Influence of pulsed electromagnetic field (PEMF) therapy on osteoarthritis in dogs","volume":"21","author":"\u0160utalo","year":"2025","journal-title":"BMC Vet Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.3390\/ani12223144","article-title":"Systematic Review of Complementary and Alternative Veterinary Medicine in Sport and Companion Animals: Therapeutic Ultrasound","volume":"12","author":"Bostr\u00f6m","year":"2022","journal-title":"Animals"},{"key":"B15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5326\/JAAHAMS-7101","article-title":"Owner perceptions of long-term systemic use of subcutaneous administration of polysulfated glycosaminoglycan","volume":"57","author":"Varcoe","year":"2020","journal-title":"J Am Anim Hosp Assoc"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tvjl.2018.02.017","article-title":"Face validity of a proposed tool for staging canine osteoarthritis: Canine OsteoArthritis Staging Tool (COAST)","volume":"235","author":"Cachon","year":"2018","journal-title":"Vet J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"789898","DOI":"10.3389\/fvets.2022.789898","article-title":"Moving beyond the limits of detection: the past, the present, and the future of diagnostic imaging in canine osteoarthritis","volume":"9","author":"Jones","year":"2022","journal-title":"Front Vet Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/vr.164.14.418","article-title":"Systematic review of the management of canine osteoarthritis","volume":"164","author":"Sanderson","year":"2009","journal-title":"Vet Rec"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1461628","DOI":"10.3389\/fvets.2024.1461628","article-title":"Response to treatment with grapiprant as part of a standard multimodal regimen in young dogs with appendicular joint osteoarthritis associated pain","volume":"11","author":"Enomoto","year":"2024","journal-title":"Front Vet Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.13948","article-title":"A Prospective, randomized, masked, placebo-controlled multisite clinical study of grapiprant, an ep4 prostaglandin receptor antagonist (PRA), in dogs with osteoarthritis","author":"Rausch-Derra","year":"2016","journal-title":"J Vet Intern Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.1055\/s-0045-1810284","article-title":"A randomized, double-blinded, Noninferiority trial evaluating the efficacy of Bedinvetmab (Librela), a fully canine anti-nerve growth factor monoclonal antibody, compared to Grapiprant for osteoarthritis pain in dogs using force plate gait analysis","volume":"38","author":"Enomoto","year":"2025","journal-title":"Vet Comp Orthop Traumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/1098612X15572062","article-title":"2015 AAHA\/AAFP pain management guidelines for dogs and cats","volume":"17","author":"Epstein","year":"2015","journal-title":"J Feline Med Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.prevetmed.2016.07.017","article-title":"The attitudes of owners and veterinary professionals in the United Kingdom to the risk of adverse events associated with using non-steroidal anti-inflammatory drugs (NSAIDs) to treat dogs with osteoarthritis","volume":"131","author":"Belshaw","year":"2016","journal-title":"Prevent Vet Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/vr.c97","article-title":"Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis","volume":"166","author":"Innes","year":"2025","journal-title":"Vet Rec"},{"key":"B25","unstructured":"Retrospective study of 240 dogs receiving gabapentin for chronic pain relief. Journal of veterinary medicine and research\n          \n          \n            \n              Davis\n              LV\n            \n            \n              Hellyer\n              PW\n            \n            \n              Downing\n              RA\n            \n            \n              Kogan\n              LR\n            \n          \n          \n          2020"},{"key":"B26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.vaa.2021.08.001","article-title":"A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis","volume":"48","author":"Corral","year":"2021","journal-title":"Vet Anaesth Analg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.vaa.2023.06.003","article-title":"A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody","volume":"50","author":"Michels","year":"2023","journal-title":"Vet Anaesth Analg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1502218","DOI":"10.3389\/fvets.2025.1502218","article-title":"A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis","volume":"12","author":"Innes","year":"2025","journal-title":"Front Vet Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/jsap.13495","article-title":"Advances in the pharmaceutical treatment options for canine osteoarthritis","volume":"63","author":"Pye","year":"2022","journal-title":"J Small Anim Pract"},{"key":"B30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5326\/JAAHA-MS-7292","article-title":"2022 AAHA pain management guidelines for dogs and cats","volume":"58","author":"Gruen","year":"2022","journal-title":"J Am Anim Hosp Assoc."},{"key":"B31","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.vaa.2025.03.001","article-title":"A case of potential rapidly progressing osteoarthritis (RPOA) in a dog during bedinvetmab treatment","volume":"52","author":"Iff","year":"2024","journal-title":"Vet Anaesth Analg"},{"key":"B32","unstructured":"Dear Veterinarian Letter notifying veterinarians about adverse events reported in dogs treated with Librela (bedinvetmab injection)."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1558222","DOI":"10.3389\/fvets.2025.1558222","article-title":"Global pharmacovigilance reporting of the first monoclonal antibody for canine osteoarthritis: a case study with bedinvetmab (LibrelaTM)","volume":"12","author":"Monteiro","year":"2025","journal-title":"Front Vet Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1581490","DOI":"10.3389\/fvets.2025.1581490","article-title":"Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)","volume":"12","author":"Farrell","year":"2025","journal-title":"Front Vet Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2460\/javma.24.10.0665","article-title":"How can the veterinary profession tackle social media misinformation?","volume":"263","author":"Moran","year":"2025","journal-title":"J Am Vet M\u00e9d Assoc"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.3390\/ani14152231","article-title":"Use of Bedinvetmab (Librela\u00ae) for canine osteoarthritis in france, germany, italy, spain, and the uk: quantitative analysis of veterinarian satisfaction and real-world treatment patterns","volume":"14","author":"Gildea","year":"2024","journal-title":"Animals"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0295840","DOI":"10.1371\/journal.pone.0295840","article-title":"Dog size and patterns of disease history across the canine age spectrum: Results from the dog aging project","volume":"19","author":"Nam","year":"2024","journal-title":"Plos ONE"},{"key":"B38","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40264-023-01302-7","article-title":"Factors associated with underreporting of adverse drug reactions by health care professionals: a systematic review update","volume":"46","author":"Garc\u00eda-Abeijon","year":"2023","journal-title":"Drug Saf"},{"key":"B39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2460\/javma.236.1.59","article-title":"Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs","volume":"236","author":"Roush","year":"2010","journal-title":"J Am Vet Med Assoc"},{"key":"B40","doi-asserted-by":"publisher","first-page":"10384","DOI":"10.3390\/ijms231810384","article-title":"A 2022 Systematic review and meta-analysis of enriched therapeutic diets and nutraceuticals in canine and feline osteoarthritis","volume":"23","author":"Barbeau-Gr\u00e9goire","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/0363546514533777","article-title":"Chondroprotection and the prevention of osteoarthritis progression of the knee","volume":"43","author":"Gallagher","year":"2014","journal-title":"Am J Sports Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2023.1033188","article-title":"et. Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: A prospective, block-randomized, double-blinded, placebo-controlled clinical trial","author":"Kampa","year":"2023","journal-title":"Front Vet Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1248417","DOI":"10.3389\/fvets.2023.1248417","article-title":"Efficacy and safety of cannabidiol for the treatment of canine osteoarthritis: a systematic review and meta-analysis of animal intervention studies","volume":"10","author":"Patikorn","year":"2023","journal-title":"Front Vet Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fvets.2018.00165","article-title":"Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs","volume":"5","author":"Gamble","year":"2018","journal-title":"Front Vet Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2460\/javma.256.12.1335","article-title":"Nutrition and nutraceuticals in the changing management of osteoarthritis for dogs and cats","volume":"256","author":"Johnson","year":"2020","journal-title":"J Am Vet Med Assoc."},{"key":"B46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fvets.2024.1464549","article-title":"Evaluation of the comparative efficacy of green lipped mussel plus krill oil extracts (EAB-277), Biota orientalis extracts or NSAIDs for the treatment of dogs with osteoarthritis associated pain: a blinded, placebo-controlled study","volume":"9","author":"Kampa","year":"2024","journal-title":"Front Vet Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s11259-010-9348-7","article-title":"The effect of weight loss on lameness in obese dogs with osteoarthritis","volume":"229","author":"Marshall","year":"2010","journal-title":"Vet Res Commun"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1814641\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:46:55Z","timestamp":1780030015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1814641\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":47,"alternative-id":["10.3389\/fvets.2026.1814641"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2026.1814641","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1814641"}}